Immunogenicity and Safety of the Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Women

Incidence of Types of Cancer among HIV-Infected Persons Compared with the General Population in the United States, 1992–2003

(2013) Pragna Patel et al.   ANNALS OF INTERNAL MEDICINE

Immunogenicity and Safety of the Human Papillomavirus 6, 11, 16, 18 Vaccine in HIV-Infected Young Women

(2013) Jessica A. Kahn et al.   CLINICAL INFECTIOUS DISEASES

Invasive Cervical Cancer Risk Among HIV-Infected Women

(2012) Alison G. Abraham et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Clinical Trial Experience With Prophylactic Human Papillomavirus 6/11/16/18 Vaccine in Young Black Women

(2012) Liana R. Clark et al.   JOURNAL OF ADOLESCENT HEALTH

Evaluation of the HPV 18 antibody response in Gardasil®vaccinees after 48 mo using a pseudovirion neutralization assay

(2012) Christine Roberts et al.   Human Vaccines & Immunotherapeutics

The humoral response to Gardasil over four years as defined by Total IgG and competitive Luminex immunoassay

(2011) Darron R. Brown et al.   Human vaccines & immunotherapeutics

A Murine Genital-Challenge Model Is a Sensitive Measure of Protective Antibodies against Human Papillomavirus Infection

(2011) S. Longet et al.   JOURNAL OF VIROLOGY

Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males

(2011) Anna R. Giuliano et al.   NEW ENGLAND JOURNAL OF MEDICINE

HPV Vaccine against Anal HPV Infection and Anal Intraepithelial Neoplasia

(2011) Joel M. Palefsky et al.   NEW ENGLAND JOURNAL OF MEDICINE

Safety and Immunogenicity of the Quadrivalent Human Papillomavirus Vaccine in HIV‐1–Infected Men

(2010) Timothy Wilkin et al.   JOURNAL OF INFECTIOUS DISEASES

Incidence and Epidemiology of Anal Cancer in the Multicenter AIDS Cohort Study

(2009) Gypsyamber DʼSouza et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24–45 years: a randomised, double-blind trial

(2009) Nubia Muñoz et al.   LANCET

Anal intraepithelial neoplasia in a multisite study of HIV-infected and high-risk HIV-uninfected women

(2008) Nancy A Hessol et al.   AIDS

HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccine

(2008) Elmar A. Joura et al.   VACCINE